Major investors see green shoots for the biotech industry

A major trust which invests in the global biotechnology industry says that the US political environment has stabilized, and uncertainty over drug pricing has lessened.

International Biotechnology Trust, which is managed by UK-based SV Life Sciences, also says that a recovery in the sector, which “has not participated in the broader market rally,” can now be expected.

Investment manager Carl Harald Janson said: “Following Donald Trump’s win, drug pricing has become a lesser area of concern and share prices have begun to recover, due to the assumption that ‘business friendly’ Republicans are unlikely to vote for price controls.”